Crystalvue Medical Co (ROCO:6527) ROCE % : 17.61% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Crystalvue Medical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Crystalvue Medical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 17.61%.

Crystalvue Medical Co ROCE % Historical Data

The historical data trend for Crystalvue Medical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crystalvue Medical Co ROCE % Chart

Crystalvue Medical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

18.76

8.82

15.08

18.47

14.35

Crystalvue Medical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															15.73	16.17	14.09	12.04	17.61

Crystalvue Medical Co ROCE % Calculation

Crystalvue Medical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	120.557	/	( ( (1012.981 - 210.034)	+	(1078.423 - 201.447) )	/ 2 )
	=	120.557	/	( (802.947	+	876.976)	/ 2 )
	=	120.557	/	839.9615
	=	14.35 %

Crystalvue Medical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	156.988	/	( ( (1078.423 - 201.447)	+	(1103.771 - 197.664) )	/ 2 )
	=	156.988	/	( ( 876.976	+	906.107 )	/ 2 )
	=	156.988	/	891.5415
	=	17.61 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Crystalvue Medical Co (ROCO:6527) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Crystalvue Medical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Crystalvue Medical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Crystalvue Medical Co (ROCO:6527) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Crystalvue Medical Co Ltd (ROCO:6527) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 116, Ln. 956, Zhongshan Road, Taoyuan District, Taoyuan, TWN, 33072

Website

http://www.crystalvue.com.tw

Crystalvue Medical Co Ltd is engaged in manufacturing and production of medical devices including chin rest, digital microscope camera, OCT, fundus camera, gastrointestinal endoscopic disposable devices and tonometer among others. It also provides FundusVue which is a diagnostic instrument for ophthalmologists to inspect and record the patients' retina.

Crystalvue Medical Co (ROCO:6527) Headlines

No Headlines